Literature DB >> 23213260

Ubiquitylation of p53 by the APC/C inhibitor Trim39.

Liguo Zhang1, Nai-Jia Huang, Chen Chen, Wanli Tang, Sally Kornbluth.   

Abstract

Tripartite motif 39 (Trim39) is a RING domain-containing E3 ubiquitin ligase able to inhibit the anaphase-promoting complex (APC/C) directly. Through analysis of Trim39 function in p53-positive and p53-negative cells, we have found, surprisingly, that p53-positive cells lacking Trim39 could not traverse the G1/S transition. This effect did not result from disinhibition of the APC/C. Moreover, although Trim39 loss inhibited etoposide-induced apoptosis in p53-negative cells, apoptosis was enhanced by Trim39 knockdown in p53-positive cells. Furthermore, we show here that the Trim39 can directly bind and ubiquitylate p53 in vitro and in vivo, leading to p53 degradation. Depletion of Trim39 significantly increased p53 protein levels and cell growth retardation in multiple cell lines. We found that the relative importance of Trim39 and the well-characterized p53-directed E3 ligase, murine double minute 2 (MDM2), varied between cell types. In cells that were relatively insensitive to the MDM2 inhibitor, nutlin-3a, apoptosis could be markedly enhanced by siRNA directed against Trim39. As such, Trim39 may serve as a potential therapeutic target in tumors with WT p53 when MDM2 inhibition is insufficient to elevate p53 levels and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23213260      PMCID: PMC3529062          DOI: 10.1073/pnas.1212047110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

2.  Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins.

Authors:  J D Reimann; B E Gardner; F Margottin-Goguet; P K Jackson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex.

Authors:  J D Reimann; E Freed; J Y Hsu; E R Kramer; J M Peters; P K Jackson
Journal:  Cell       Date:  2001-06-01       Impact factor: 41.582

4.  Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.

Authors:  Suzanne Camus; Maureen Higgins; David P Lane; Sonia Lain
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

5.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Authors:  J Lin; J Chen; B Elenbaas; A J Levine
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

10.  The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1.

Authors:  Nai-Jia Huang; Liguo Zhang; Wanli Tang; Chen Chen; Chih-Sheng Yang; Sally Kornbluth
Journal:  J Cell Biol       Date:  2012-04-23       Impact factor: 10.539

View more
  26 in total

1.  Mitotic phosphatase activity is required for MCC maintenance during the spindle checkpoint.

Authors:  Kristen M Foss; Alexander C Robeson; Sally Kornbluth; Liguo Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 2.  Precision autophagy directed by receptor regulators - emerging examples within the TRIM family.

Authors:  Tomonori Kimura; Michael Mandell; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

3.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

Review 4.  TRIMming p53's anticancer activity.

Authors:  S Elabd; G Meroni; C Blattner
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

Review 5.  Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases.

Authors:  Liubov V Gushchina; Thomas A Kwiatkowski; Sayak Bhattacharya; Noah L Weisleder
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

6.  Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3.

Authors:  Meenakshi Basu-Shrivastava; Barbara Mojsa; Stéphan Mora; Ian Robbins; Guillaume Bossis; Iréna Lassot; Solange Desagher
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 15.828

7.  Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11.

Authors:  Chen Chen; Liguo Zhang; Nai-Jia Huang; Bofu Huang; Sally Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin.

Authors:  Masanobu Suzuki; Masashi Watanabe; Yuji Nakamaru; Dai Takagi; Hidehisa Takahashi; Satoshi Fukuda; Shigetsugu Hatakeyama
Journal:  Cell Mol Life Sci       Date:  2015-09-12       Impact factor: 9.261

9.  Trim58 degrades Dynein and regulates terminal erythropoiesis.

Authors:  Christopher S Thom; Elizabeth A Traxler; Eugene Khandros; Jenna M Nickas; Olivia Y Zhou; Jacob E Lazarus; Ana P G Silva; Dolly Prabhu; Yu Yao; Chiaka Aribeana; Serge Y Fuchs; Joel P Mackay; Erika L F Holzbaur; Mitchell J Weiss
Journal:  Dev Cell       Date:  2014-09-18       Impact factor: 12.270

10.  Molecular dynamics of the full-length p53 monomer.

Authors:  Giovanni Chillemi; Pavel Davidovich; Marco D'Abramo; Tazhir Mametnabiev; Alexander Vasilievich Garabadzhiu; Alessandro Desideri; Gerry Melino
Journal:  Cell Cycle       Date:  2013-09-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.